Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

First patient dosed in phase 3 study with avatrombopag for treatment of ITP in children

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the first patient has been dosed with avatrombopag, a thrombopoietin receptor agonist (TPO-RA), for treatment of immune thrombocytopenia (ITP) in pediatric patients. This phase 3 study, the first the evaluate avatrombopag in children, will evaluate efficacy, safety, and pharmacokinetics of avatrombopag in the treatment of pediatric subjects with ITP. “We are excited to announce the start of this important study,” says Ravi Rao, Head of Research & Development at Sobi. “Our hope is to provide a new treatment option

Alimak Group appoints Salomeh Tafazoli as EVP Industrial division

Alimak Group has appointed Salomeh Tafazoli as EVP Industrial division, effective as of June 1, 2021.Salomeh Tafazoli is currently Vice President Sales and Marketing EMEA at Snap-on Equipment, an American based company listed on NYSE. She has extensive experience from the automotive industry, working with both products and services, and has previously held various strategic and commercial roles within Volvo Group and Car-O-Liner Group. “I am very pleased to welcome Salomeh Tafazoli to Alimak Group. Her experience from international industrial businesses and her proven ability to balance

SBB’s mandatory offer to shareholders in Offentliga Hus – timetable reminder and announcement that the ownership amounts to 72.79 percent

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further registration documents, filings or other measures in addition to those required under Swedish law.On 18 December 2020, Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB” or the “Company”) announced an acquisition

Net Trading Group NTG AB: Board change

The company has made some formal position changes. Morten Revill is taking charge as chairman of the board. Morten Hansson, who has several years as a former CEO of Net Trading Group, is appointed as new CEO. Stein Bemer is relieved as chairman.  - Lightcircle/NTG is soon approaching extremely exciting opportunities, and I am truly looking forward to taking charge as chairman. We as a company are lucky to have Morten Hansson still on board with his immense commercial experience. On behalf of me and the rest of the board I would like to thank Stein for his effort and wish him the best

2020 Bulkers Ltd. (2020) – Annual Report 2020

Hamilton, Bermuda, March 12, 2021 2020 Bulkers Ltd. announces that the Annual Report for the year ended December 31, 2020 has been approved by the Board of Directors of the Company. There were no changes to the consolidated statements of operations or consolidated balance sheets compared to those presented on January 28, 2021. The Annual Report for 2020 is enclosed and is also available on the Company's website: https://2020bulkers.com

Sectra’s nine-month interim report 2020/2021: Increased order bookings and the industry’s most satisfied customers for the eighth consecutive year

Press release – Linköping, March 12, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has received a top ranking in customer satisfaction surveys in the category of diagnostic imaging systems for radiology in the US, Canada and Europe as well as in the category of digital pathology. As a result of having the market’s most satisfied customers for many years, demand for the company’s offerings is high and order bookings increased 79% compared with the year-earlier period. The third quarter of the preceding fiscal year was

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for February 2021

Hamilton, Bermuda, March 12, 2021 Commercial update: In February 2021, the Company achieved average time charter equivalent earnings of approximately US$18,800 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$18,600 per day, gross, including average daily scrubber benefits of approximately US$1,200 per day. Bulk Shanghai earned approximately US$19,100 per day, gross, including average daily scrubber benefits of approximately US$800 per day. Bulk Shenzhen earned approximately US$19,800 per day, gross. The Baltic 5TC Capesize

Fortum publishes restated comparison figures following the preliminary purchase price allocation of the Uniper acquisition

FORTUM CORPORATION STOCK EXCHANGE RELEASE 12 MARCH 2021 AT 9:01 EET Release category: Other information disclosed according to the rules of the exchange Fortum is finalising the purchase price allocation of the Uniper acquisition which will be completed within the one-year window from the acquisition date in the first quarter of 2021. Fortum presents the preliminary purchase price allocation for the Uniper acquisition in the Financial Statements Bulletin for 2020, published today. The preliminary purchase price allocation resulted in adjustments to Uniper’s 31 March 2020 opening

Modus Therapeutics - Claes Lindblad Joins as Chief Financial Officer

STOCKHOLM, SWEDEN – 12 March 2021: Modus Therapeutics Holding AB, a company developing innovative treatments for patients with high unmet medical needs, announces that it has appointed Claes Lindblad as its new Chief Financial Officer. He joins the Company as it looks for funding to support the development of sevuparin, into a new important potential treatment for sepsis/septic shock, and other severe inflammatory complications that millions of patients suffer from because of serious medical conditions such as major trauma and surgery, autoimmunity, and viral infection.In many patients,

SpareBank 1 SR-Bank ASA (SRBNK); The shares will be quoted ex-dividend today

The shares in SpareBank 1 SR-Bank ASA (SRBNK) will be traded ex-dividend as from today, 12 March 2021. A dividend of NOK 5.50 per share will be distributed as from 19 March 2021 to registered shareholders as at 11. March 2021. Stavanger, 12 March 2021 Contact:Stian Helgøy, Vice President Investor Relations, Tel. +47 906 52 173 This information is disclosed in compliance with section 5-12 of the Securities Trading Act.

Optomed Annual Report 2020 published

Optomed Plc         Stock Exchange Release    12 March 2021 at 9.00, Helsinki Optomed Annual Report 2020 published Optomed's Annual Report 2020 has been published. The Annual Report includes the company's consolidated and parent company financial statements, the report of the board of directors, corporate governance statement and remuneration report for governing bodies. Optomed publishes its financial statements in accordance with the European Single Electronic Format (ESEF) reporting requirements. As per ESEF requirements, the primary statements have been labelled with XBRL tags,

Elkem ASA – Annual report for 2020

Oslo, 12 March 2021 Elkem ASA has today published its annual report, including the ESG report, for the financial year ended 31 December 2020. In his letter to shareholders, Elkem’s CEO Michael Koenig writes: “The world experienced a public health crisis and an economic crisis in 2020. Elkem has met these challenges well, by focusing on three priorities: Putting health and safety first, maintaining high and stable production while positioning for profitable growth.” In 2020, Elkem delivered a total operating income of NOK 24,691 million, up 9% from NOK 22,668 million in 2019.

Anders Svensson joins OssDsign as Chief Financial Officer

OssDsign AB (publ) (“OssDsign” or the “Company”) today announces that Anders Svensson, the Company’s current interim CFO, will take on the role permanently from April 1, 2021.OssDsign has grown rapidly over the last several years and is now a global company with operations across three continents.   Anders Svensson comes with a strong financial and strategic background and has senior management experience within a number of high growth companies. Prior to joining OssDsign, Anders was CFO for both Bluefish Pharmaceuticals and Aura Light, as well as being the CEO for Aura Light’s US

Fortum Financial Statements Bulletin 2020: Good performance in a challenging year – Strategy updated to drive the clean energy transition

FORTUM CORPORATION FINANCIAL STATEMENTS BULLETIN 2020 12 MARCH 2021 AT 9:00 EET This release is a summary of Fortum’s Financial Statements Bulletin 2020. The complete report is attached to this release as a pdf-file. It is also available on the company's website at www.fortum.com/investors. October-December 2020 · Comparable EBITDA was EUR 1,247 (552) million · Comparable operating profit was EUR 928 (398) million due to Uniper’s fourth-quarter results · Accounting effect, mainly one-time, of purchase price allocation of Uniper transaction EUR 64 million on the comparable

Christian Sagild proposed as new member of the Board of Directors for the purpose of being elected new Chairman of Penneo

Company Announcement No. 4-2021Copenhagen, 12 March, 2021  As a new candidate, the Board of Directors of Penneo will propose Christian Sagild. The rest of the Board members will stand for re-election at the AGM. It is the intention that, after the AGM, the Board of Directors  will elect Christian Sagild as new chairman. Morten Elk, Chairman of the Board of Directors of Penneo, comments: “Penneo has become the de facto standard in the Nordic market for automated processes regarding identity, signing and workflows in the audit sector and other document-intensive industries.

Magnolia Bostad forms JV with KF Fastigheter and acquires land in Upplands-Bro

Magnolia Bostad forms a JV with KF Fastigheter for the joint development of land in a new residential area by Lake Mälaren in Upplands-Bro municipality. In total, around 950 residential units with 80,000 m[2 ]of GFA will be developed.Magnolia Bostad and KF Fastigheter have formed a JV company through Magnolia Bostad buying 50% of the Group that is currently owned by KF, which includes the properties. The building rights are well-situated in Bro Mälarstrand and many residencia units have a view overlooking Lake Mälaren. The area will also include a marina, a promenade with jetties and a

Fabege signs land allocation agreement in Flemingsberg

Fabege and Huddinge Municipality have signed an agreement on land allocation in Flemingsbergsdalen. The agreement provides for Fabege to be granted exclusive rights to negotiate with the municipality on land acquisition and development on the basis that Fabege will develop the land in accordance with the existing planning programme.The intention of the parties is for the areas of land allocated to be subject to new local plans. The current area covers a total of about 220,000 sqm, of which 190,000 sqm is for commercial space and 30,000 sqm for residential. Based on agreed prices and the

Serneke evaluates existing bond financing

On December 17, 2020, Serneke Group AB (“Serneke” or the “Company”) announced that it had secured the financing for Karlatornet, which will be the Nordic region’s tallest skyscraper, in a transaction with Fastighets AB Balder ("Balder") and a construction credit facility of approximately SEK 3 billion. In addition, Serneke has entered into a contract for the remaining project development and contract work at a fixed price of approximately SEK 3.2 billion. Occupation of Karlatornet is estimated to begin during the second half of 2023 and at completion Serneke will have received its invested

notice of annual general meeting 2021

The shareholders of Akelius Residential Property AB (publ) are summoned to the annual general meeting,2021-04-09. For the purpose of countering the spread of the Corona virus, the board of directors has resolved that the annual general meeting shall be carried out through postal voting alone, without physical presence of shareholders, representatives and third parties. The shareholders will be able to participate in a digital presentation and Q&A meeting with the Chairman of the board, CEO, CFO and auditor to be held at 10.00 on 2021-04-07.A shareholder who wishes to participate

BERGENBIO COMPLETES ENROLMENT INTO LATEST COHORT OF PHASE II BEMCENTINIB COMBINATION STUDY IN REFRACTORY NSCLC

Bergen, Norway, 12 March 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that it has completed enrolment into Cohort C1 of its Phase II study (BGBC008) of bemcentinib in combination with anti-PD-1 therapy Keytruda[®] (pembrolizumab) in refractory non-small cell lung cancer (NSCLC) patients. The BGBC008 trial ClinicalTrials.gov Identifier: NCT03184571 is being conducted in three cohorts evaluating the safety and benefit of bemcentinib and pembrolizumab

Kesko’s comparable sales grew in February

Kesko Group's sales totalled €797.9 million in February 2021, representing an increase of 3.0% in comparable terms on the previous year.“Kesko's sales grew in comparable terms on the year before. Grocery sales to K-food stores increased clearly, but sales in the grocery trade division were also impacted by the decrease in Kespro’s sales due to Covid-19 restrictions. In the building and technical trade division, growth continued strong. Sales also grew in the car trade,” says Kesko’s President and CEO Mikko Helander. Sales in the grocery trade division totalled €423.3 million in February,

Componenta’s Annual Review for 2020 published

Componenta Corporation, Stock Exchange Release, 12 March 2021 at 8.00 am Finnish time Componenta’s Annual Review for 2020 has been published in Finnish and English at company’s website at www.componenta.com. The Annual Review includes the consolidated Financial Statements, the Financial Statements of the parent company and the Report of the Board of Directors for the period 1 January – 31 December 2020. The Financial Statements in Finnish are published for the first time in accordance with European Single Electronic Format (ESEF) reporting requirements. The Financial Review is

Componenta’s Auditor’s report for the financial period 1 january – 31 December 2020

Componenta Corporation, Stock Exchange Release, 12 March 2021 at 8.00 am Finnish time The Auditor of Componenta Corporation has today issued the following Auditor’s Report for the financial period 1 January - 31 December 2020. “Auditor’s Report (Translation of the Finnish Original) To the Annual General Meeting of Componenta Oyj Report on the Audit of the Financial Statements  Opinion In our opinion •    the consolidated financial statements give a true and fair view of the group’s financial position and financial performance and cash flows in accordance with

There are no items matching the current filter
There are no more items matching the current filter
Back to top